Condition
Chronic Wound Care
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07258381Not ApplicableNot Yet Recruiting
Mailuo Shutong Pills for Diabetic Wound Healing: A Multicenter Randomized Trial
NCT07096830Not ApplicableNot Yet RecruitingPrimary
Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing
NCT06810726Phase 2Recruiting
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
NCT01333670Phase 3Completed
Efficacy of Prontosan Solution on Chronic Ulcers
NCT01048307Not ApplicableCompleted
Effect of Prontosan Wound Irrigation Solution on Venous Ulcers
Showing all 5 trials